NEW ISSUE
Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …
February 19, 2021
Showing 1-8 of 8 articles
Entrapment of the Impella heart pump in the mitral subvalvular apparatus
February 5, 2021 | 10.4244/EIJ-D-19-00942
Adverse events with orbital atherectomy: an analytic review of the MAUDE database
July 17, 2020 | 10.4244/EIJ-D-19-00295
Coronary interventions
Chordae Tendineae Rupture and Iatrogenic Severe Mitral Regurgitation Related to Impella February 18, 2020 | 10.4244/EIJ-D-19-00942
Reply to the letter to the editor “Impella device use in high-risk PCI”
October 18, 2019 | 10.4244/EIJ-D-19-00279R
Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial
August 9, 2019 | 10.4244/EIJ-D-19-00263
Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database
May 20, 2019 | 10.4244/EIJ-D-18-01021
Coronary interventions
State of the art: evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses – from debulking to plaque modification, a 40-year-long journey August 25, 2017 | 10.4244/EIJ-D-17-00473
Coronary interventions
Orbital atherectomy treatment of severely calcified coronary lesions in patients with impaired left ventricular ejection fraction: one-year outcomes from the ORBIT II study June 20, 2017 | 10.4244/EIJ-D-16-00301